ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting rhGH (LAGH) Market Research Report 2025
Published Date: 2025-06-04
|
Report Code: QYRE-Auto-17Z16449
Home | Market Reports
Global Long acting rhGH LAGH Market Research Report 2023
BUY CHAPTERS

Global Long-acting rhGH (LAGH) Market Research Report 2025

Code: QYRE-Auto-17Z16449
Report
2025-06-04
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
GeneScience Pharmaceutical
OPKO Health
Ascendis Pharma
Amunix Pharmaceuticals, Inc.
I-MAB Biopharma

Long-acting rhGH (LAGH) Market

The global market for Long-acting rhGH (LAGH) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant human growth hormone is a protein that is manufactured to be nearly identical to the main form of the naturally occurring human growth hormone. This hormone can stimulate tissue growth, linear growth (height), and protein, carbohydrate, lipid, and mineral metabolism. It has approved indications in both the adult and pediatric populations.
Short-acting growth hormone requires daily injections, while long-acting recombinant human growth hormone only needs to be administered once a week.
North American market for Long-acting rhGH (LAGH) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Long-acting rhGH (LAGH) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Long-acting rhGH (LAGH) include Novo Nordisk, GeneScience Pharmaceutical, Pfizer, OPKO Health, Ascendis Pharma, Amunix Pharmaceuticals, Inc., I-MAB Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting rhGH (LAGH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting rhGH (LAGH).
The Long-acting rhGH (LAGH) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting rhGH (LAGH) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting rhGH (LAGH) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting rhGH (LAGH) Market Report

Report Metric Details
Report Name Long-acting rhGH (LAGH) Market
Segment by Type
  • Powder
  • Liquid
Segment by Application
  • Growth Hormone Deficiency (GHD)
  • Turner Syndrome
  • Chronic Renal Insufficiency
  • Prader Willi Syndrome
  • Small for Gestational Age
  • SHOX Deficiency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, GeneScience Pharmaceutical, Pfizer, OPKO Health, Ascendis Pharma, Amunix Pharmaceuticals, Inc., I-MAB Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting rhGH (LAGH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting rhGH (LAGH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Long-acting rhGH (LAGH) Market report?

Ans: The main players in the Long-acting rhGH (LAGH) Market are Novo Nordisk, GeneScience Pharmaceutical, Pfizer, OPKO Health, Ascendis Pharma, Amunix Pharmaceuticals, Inc., I-MAB Biopharma

What are the Application segmentation covered in the Long-acting rhGH (LAGH) Market report?

Ans: The Applications covered in the Long-acting rhGH (LAGH) Market report are Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others

What are the Type segmentation covered in the Long-acting rhGH (LAGH) Market report?

Ans: The Types covered in the Long-acting rhGH (LAGH) Market report are Powder, Liquid

1 Long-acting rhGH (LAGH) Market Overview
1.1 Product Definition
1.2 Long-acting rhGH (LAGH) by Type
1.2.1 Global Long-acting rhGH (LAGH) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Long-acting rhGH (LAGH) by Application
1.3.1 Global Long-acting rhGH (LAGH) Market Value by Application (2024 VS 2031)
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Global Long-acting rhGH (LAGH) Market Size Estimates and Forecasts
1.4.1 Global Long-acting rhGH (LAGH) Revenue 2020-2031
1.4.2 Global Long-acting rhGH (LAGH) Sales 2020-2031
1.4.3 Global Long-acting rhGH (LAGH) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Long-acting rhGH (LAGH) Market Competition by Manufacturers
2.1 Global Long-acting rhGH (LAGH) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Long-acting rhGH (LAGH) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Long-acting rhGH (LAGH) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Long-acting rhGH (LAGH), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting rhGH (LAGH), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting rhGH (LAGH), Product Type & Application
2.7 Global Key Manufacturers of Long-acting rhGH (LAGH), Date of Enter into This Industry
2.8 Global Long-acting rhGH (LAGH) Market Competitive Situation and Trends
2.8.1 Global Long-acting rhGH (LAGH) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting rhGH (LAGH) Players Market Share by Revenue
2.8.3 Global Long-acting rhGH (LAGH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting rhGH (LAGH) Market Scenario by Region
3.1 Global Long-acting rhGH (LAGH) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Long-acting rhGH (LAGH) Sales by Region: 2020-2031
3.2.1 Global Long-acting rhGH (LAGH) Sales by Region: 2020-2025
3.2.2 Global Long-acting rhGH (LAGH) Sales by Region: 2026-2031
3.3 Global Long-acting rhGH (LAGH) Revenue by Region: 2020-2031
3.3.1 Global Long-acting rhGH (LAGH) Revenue by Region: 2020-2025
3.3.2 Global Long-acting rhGH (LAGH) Revenue by Region: 2026-2031
3.4 North America Long-acting rhGH (LAGH) Market Facts & Figures by Country
3.4.1 North America Long-acting rhGH (LAGH) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Long-acting rhGH (LAGH) Sales by Country (2020-2031)
3.4.3 North America Long-acting rhGH (LAGH) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting rhGH (LAGH) Market Facts & Figures by Country
3.5.1 Europe Long-acting rhGH (LAGH) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Long-acting rhGH (LAGH) Sales by Country (2020-2031)
3.5.3 Europe Long-acting rhGH (LAGH) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting rhGH (LAGH) Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting rhGH (LAGH) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Long-acting rhGH (LAGH) Sales by Region (2020-2031)
3.6.3 Asia Pacific Long-acting rhGH (LAGH) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting rhGH (LAGH) Market Facts & Figures by Country
3.7.1 Latin America Long-acting rhGH (LAGH) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Long-acting rhGH (LAGH) Sales by Country (2020-2031)
3.7.3 Latin America Long-acting rhGH (LAGH) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-acting rhGH (LAGH) Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting rhGH (LAGH) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Long-acting rhGH (LAGH) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Long-acting rhGH (LAGH) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting rhGH (LAGH) Sales by Type (2020-2031)
4.1.1 Global Long-acting rhGH (LAGH) Sales by Type (2020-2025)
4.1.2 Global Long-acting rhGH (LAGH) Sales by Type (2026-2031)
4.1.3 Global Long-acting rhGH (LAGH) Sales Market Share by Type (2020-2031)
4.2 Global Long-acting rhGH (LAGH) Revenue by Type (2020-2031)
4.2.1 Global Long-acting rhGH (LAGH) Revenue by Type (2020-2025)
4.2.2 Global Long-acting rhGH (LAGH) Revenue by Type (2026-2031)
4.2.3 Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2020-2031)
4.3 Global Long-acting rhGH (LAGH) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Long-acting rhGH (LAGH) Sales by Application (2020-2031)
5.1.1 Global Long-acting rhGH (LAGH) Sales by Application (2020-2025)
5.1.2 Global Long-acting rhGH (LAGH) Sales by Application (2026-2031)
5.1.3 Global Long-acting rhGH (LAGH) Sales Market Share by Application (2020-2031)
5.2 Global Long-acting rhGH (LAGH) Revenue by Application (2020-2031)
5.2.1 Global Long-acting rhGH (LAGH) Revenue by Application (2020-2025)
5.2.2 Global Long-acting rhGH (LAGH) Revenue by Application (2026-2031)
5.2.3 Global Long-acting rhGH (LAGH) Revenue Market Share by Application (2020-2031)
5.3 Global Long-acting rhGH (LAGH) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Long-acting rhGH (LAGH) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 GeneScience Pharmaceutical
6.2.1 GeneScience Pharmaceutical Company Information
6.2.2 GeneScience Pharmaceutical Description and Business Overview
6.2.3 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product Portfolio
6.2.5 GeneScience Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Long-acting rhGH (LAGH) Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 OPKO Health
6.4.1 OPKO Health Company Information
6.4.2 OPKO Health Description and Business Overview
6.4.3 OPKO Health Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 OPKO Health Long-acting rhGH (LAGH) Product Portfolio
6.4.5 OPKO Health Recent Developments/Updates
6.5 Ascendis Pharma
6.5.1 Ascendis Pharma Company Information
6.5.2 Ascendis Pharma Description and Business Overview
6.5.3 Ascendis Pharma Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ascendis Pharma Long-acting rhGH (LAGH) Product Portfolio
6.5.5 Ascendis Pharma Recent Developments/Updates
6.6 Amunix Pharmaceuticals, Inc.
6.6.1 Amunix Pharmaceuticals, Inc. Company Information
6.6.2 Amunix Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product Portfolio
6.6.5 Amunix Pharmaceuticals, Inc. Recent Developments/Updates
6.7 I-MAB Biopharma
6.7.1 I-MAB Biopharma Company Information
6.7.2 I-MAB Biopharma Description and Business Overview
6.7.3 I-MAB Biopharma Long-acting rhGH (LAGH) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 I-MAB Biopharma Long-acting rhGH (LAGH) Product Portfolio
6.7.5 I-MAB Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting rhGH (LAGH) Industry Chain Analysis
7.2 Long-acting rhGH (LAGH) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting rhGH (LAGH) Production Mode & Process Analysis
7.4 Long-acting rhGH (LAGH) Sales and Marketing
7.4.1 Long-acting rhGH (LAGH) Sales Channels
7.4.2 Long-acting rhGH (LAGH) Distributors
7.5 Long-acting rhGH (LAGH) Customer Analysis
8 Long-acting rhGH (LAGH) Market Dynamics
8.1 Long-acting rhGH (LAGH) Industry Trends
8.2 Long-acting rhGH (LAGH) Market Drivers
8.3 Long-acting rhGH (LAGH) Market Challenges
8.4 Long-acting rhGH (LAGH) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
GeneScience Pharmaceutical
OPKO Health
Ascendis Pharma
Amunix Pharmaceuticals, Inc.
I-MAB Biopharma
List of Tables
 Table 1. Global Long-acting rhGH (LAGH) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Long-acting rhGH (LAGH) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Long-acting rhGH (LAGH) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Long-acting rhGH (LAGH) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Long-acting rhGH (LAGH) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Long-acting rhGH (LAGH) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Long-acting rhGH (LAGH) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Long-acting rhGH (LAGH) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Long-acting rhGH (LAGH), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting rhGH (LAGH), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting rhGH (LAGH), Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting rhGH (LAGH), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting rhGH (LAGH) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting rhGH (LAGH) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting rhGH (LAGH) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Long-acting rhGH (LAGH) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Long-acting rhGH (LAGH) Sales Market Share by Region (2020-2025)
 Table 19. Global Long-acting rhGH (LAGH) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Long-acting rhGH (LAGH) Sales Market Share by Region (2026-2031)
 Table 21. Global Long-acting rhGH (LAGH) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Long-acting rhGH (LAGH) Revenue Market Share by Region (2020-2025)
 Table 23. Global Long-acting rhGH (LAGH) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Long-acting rhGH (LAGH) Revenue Market Share by Region (2026-2031)
 Table 25. North America Long-acting rhGH (LAGH) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Long-acting rhGH (LAGH) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Long-acting rhGH (LAGH) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Long-acting rhGH (LAGH) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Long-acting rhGH (LAGH) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Long-acting rhGH (LAGH) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Long-acting rhGH (LAGH) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Long-acting rhGH (LAGH) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Long-acting rhGH (LAGH) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Long-acting rhGH (LAGH) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Long-acting rhGH (LAGH) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Long-acting rhGH (LAGH) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Long-acting rhGH (LAGH) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Long-acting rhGH (LAGH) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Long-acting rhGH (LAGH) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Long-acting rhGH (LAGH) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Long-acting rhGH (LAGH) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Long-acting rhGH (LAGH) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Long-acting rhGH (LAGH) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Long-acting rhGH (LAGH) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Long-acting rhGH (LAGH) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Long-acting rhGH (LAGH) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Long-acting rhGH (LAGH) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Long-acting rhGH (LAGH) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Long-acting rhGH (LAGH) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Long-acting rhGH (LAGH) Sales (K Units) by Type (2020-2025)
 Table 51. Global Long-acting rhGH (LAGH) Sales (K Units) by Type (2026-2031)
 Table 52. Global Long-acting rhGH (LAGH) Sales Market Share by Type (2020-2025)
 Table 53. Global Long-acting rhGH (LAGH) Sales Market Share by Type (2026-2031)
 Table 54. Global Long-acting rhGH (LAGH) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Long-acting rhGH (LAGH) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2020-2025)
 Table 57. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2026-2031)
 Table 58. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Long-acting rhGH (LAGH) Sales (K Units) by Application (2020-2025)
 Table 61. Global Long-acting rhGH (LAGH) Sales (K Units) by Application (2026-2031)
 Table 62. Global Long-acting rhGH (LAGH) Sales Market Share by Application (2020-2025)
 Table 63. Global Long-acting rhGH (LAGH) Sales Market Share by Application (2026-2031)
 Table 64. Global Long-acting rhGH (LAGH) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Long-acting rhGH (LAGH) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Long-acting rhGH (LAGH) Revenue Market Share by Application (2020-2025)
 Table 67. Global Long-acting rhGH (LAGH) Revenue Market Share by Application (2026-2031)
 Table 68. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Long-acting rhGH (LAGH) Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. GeneScience Pharmaceutical Company Information
 Table 76. GeneScience Pharmaceutical Description and Business Overview
 Table 77. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product
 Table 79. GeneScience Pharmaceutical Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Long-acting rhGH (LAGH) Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. OPKO Health Company Information
 Table 86. OPKO Health Description and Business Overview
 Table 87. OPKO Health Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. OPKO Health Long-acting rhGH (LAGH) Product
 Table 89. OPKO Health Recent Developments/Updates
 Table 90. Ascendis Pharma Company Information
 Table 91. Ascendis Pharma Description and Business Overview
 Table 92. Ascendis Pharma Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ascendis Pharma Long-acting rhGH (LAGH) Product
 Table 94. Ascendis Pharma Recent Developments/Updates
 Table 95. Amunix Pharmaceuticals, Inc. Company Information
 Table 96. Amunix Pharmaceuticals, Inc. Description and Business Overview
 Table 97. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product
 Table 99. Amunix Pharmaceuticals, Inc. Recent Developments/Updates
 Table 100. I-MAB Biopharma Company Information
 Table 101. I-MAB Biopharma Description and Business Overview
 Table 102. I-MAB Biopharma Long-acting rhGH (LAGH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. I-MAB Biopharma Long-acting rhGH (LAGH) Product
 Table 104. I-MAB Biopharma Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Long-acting rhGH (LAGH) Distributors List
 Table 108. Long-acting rhGH (LAGH) Customers List
 Table 109. Long-acting rhGH (LAGH) Market Trends
 Table 110. Long-acting rhGH (LAGH) Market Drivers
 Table 111. Long-acting rhGH (LAGH) Market Challenges
 Table 112. Long-acting rhGH (LAGH) Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting rhGH (LAGH)
 Figure 2. Global Long-acting rhGH (LAGH) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-acting rhGH (LAGH) Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Long-acting rhGH (LAGH) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Long-acting rhGH (LAGH) Market Share by Application: 2024 & 2031
 Figure 8. Growth Hormone Deficiency (GHD)
 Figure 9. Turner Syndrome
 Figure 10. Chronic Renal Insufficiency
 Figure 11. Prader Willi Syndrome
 Figure 12. Small for Gestational Age
 Figure 13. SHOX Deficiency
 Figure 14. Others
 Figure 15. Global Long-acting rhGH (LAGH) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Long-acting rhGH (LAGH) Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Long-acting rhGH (LAGH) Sales (2020-2031) & (K Units)
 Figure 18. Global Long-acting rhGH (LAGH) Average Price (US$/Unit) & (2020-2031)
 Figure 19. Long-acting rhGH (LAGH) Report Years Considered
 Figure 20. Long-acting rhGH (LAGH) Sales Share by Manufacturers in 2024
 Figure 21. Global Long-acting rhGH (LAGH) Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Long-acting rhGH (LAGH) Players: Market Share by Revenue in Long-acting rhGH (LAGH) in 2024
 Figure 23. Long-acting rhGH (LAGH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Long-acting rhGH (LAGH) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Long-acting rhGH (LAGH) Sales Market Share by Country (2020-2031)
 Figure 26. North America Long-acting rhGH (LAGH) Revenue Market Share by Country (2020-2031)
 Figure 27. United States Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Long-acting rhGH (LAGH) Sales Market Share by Country (2020-2031)
 Figure 30. Europe Long-acting rhGH (LAGH) Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Long-acting rhGH (LAGH) Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Long-acting rhGH (LAGH) Revenue Market Share by Region (2020-2031)
 Figure 38. China Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Long-acting rhGH (LAGH) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Long-acting rhGH (LAGH) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Long-acting rhGH (LAGH) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Long-acting rhGH (LAGH) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Long-acting rhGH (LAGH) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Long-acting rhGH (LAGH) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Long-acting rhGH (LAGH) by Type (2020-2031)
 Figure 57. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Long-acting rhGH (LAGH) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Long-acting rhGH (LAGH) by Application (2020-2031)
 Figure 60. Global Long-acting rhGH (LAGH) Price (US$/Unit) by Application (2020-2031)
 Figure 61. Long-acting rhGH (LAGH) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions